In prokaryotic transcription regulation, several host factors form a complex with RNA polymerase and the nascent mRNA. As part of a process known as antitermination, two of these host factors, NusB and NusE, bind to form a heterodimer, which interacts with a specific boxA site on the RNA. The NusB/NusE/boxA RNA ternary complex interacts with the RNA polymerase transcription complex, stabilizing it and allowing transcription past premature termination points. The NusB protein also binds boxA RNA individually and retains all specificity for boxA. However, NusE increases the affinity of RNA to NusB in the ternary complex, which contributes to efficient antitermination. To understand the molecular mechanism of the process, we have determined the structure of NusB from the thermophilic bacterium Aquifex aeolicus and studied the interaction of NusB and NusE. We characterize this binding interaction using NMR, isothermal titration calorimetry, gel filtration, and analytical ultracentrifugation. The binding site of NusE on NusB was determined using NMR chemical shift perturbation studies. We have also determined the NusE binding site in the ternary Escherichia coli NusB/NusE/boxA RNA complex and show that it is very similar to that in the NusB/NusE complex. There is one loop of residues (from 113 to 118 in NusB) affected by NusE binding in the ternary complex but not in the binary complex. This difference may be correlated to an increase in binding affinity of RNA for the NusB/NusE complex.
Introduction
Antitermination is a critical event for genetic regulation of transcription in both eukaryotic and prokaryotic cells. Antitermination involves the interplay of protein host factors with RNA and the RNA polymerase transcription complex to allow transcription through early termination sites. 1 The transcriptional regulation process in bacteriophage λ can be viewed as a paradigm for antitermination. In phage λ antitermination, the N protein gene product from bacteriophage λ recognizes the nascent mRNA form of the N utilization site (nut).
2 N and several other host proteins, such as NusA, NusB, NusE, and NusG, associate with nut site RNA and the RNA polymerase complex and stabilize transcription for up to several kilobases downstream. 1 The nut site is composed of a 12-base single-stranded boxA RNA component and a hairpin structured boxB RNA component. The N protein recognizes the boxB RNA site and associates with RNA polymerase through NusA. NusG binds to both NusA and RNA polymerase and can also override defective antitermination inferred by a NusA mutation. 3 The role of NusB is to interact with the boxA component of the nut site in bacteriophage λ. NusE, another host factor, interacts with NusB 1 and increases the affinity of boxA RNA to the complex. NusE also stabilizes the NusB/NusE/RNA ternary complex, 4 which presumably associates with RNA polymerase through NusE. 1, 5, 6 However, the mechanism by which NusE enhances the interaction of NusB and boxA RNA to facilitate antitermination is not well understood. Insights into these fundamental protein-protein and protein-RNA interactions are applicable to understanding events in both prokaryotic and eukaryotic genetic regulation.
Previous research has indicated that NusB binds to NusE to form a heterodimer, which then binds to boxA RNA. 4 A surface plasmon resonance study showed that both NusB protein from Escherichia coli (EcNusB) and coexpressed EcNusB/EcNusE bind to boxA RNA, although the coexpressed EcNusB/ EcNusE has 10-fold higher affinity toward the RNA. 7 A recent study using fluorescence anisotropy not only confirms the high affinity of the ternary complex but also suggests nonspecific interactions between NusE and boxA RNA in the absence of NusB. 8 In addition, a study of the NusB/NusE complex from Mycobacterium tuberculosis was reported. 9 These results, which were based on isothermal titration calorimetry (ITC), ultracentrifugation, and NMR, indicated binding between the NusB and NusE proteins from M. tuberculosis (MtbNusB and MtbNusE, respectively); however, the binding site was not identified in that study. 9 The structure has been reported for the E. coli, 10 M. tuberculosis, 11 and Thermotoga maritima 12 NusB proteins. The NusE protein, also known as ribosomal protein S10, is only partially folded in the absence of the ribosome and has very limited solubility. 7, 8 Our initial attempts to study the EcNusB/EcNusE complex were hindered by the poor solution behavior of EcNusE. Since proteins from thermopiles are often more stable than those from mesophilic bacteria, we explored the NusE protein from Aquifex aeolicus (AqNusE). We found AqNusE to be more soluble and better behaved than EcNusE and have determined that the AqNusB and AqNusE proteins also bind to form a heterodimer. Since the interaction of NusB/NusE/boxA RNA is critical to the antitermination process, studies on the binary and ternary associations are essential to understand the interplay of these host factors. Toward this end, we have characterized the AqNusB and AqNusE proteins using circular dichroism (CD), size-exclusion chromatography, and analytical ultracentrifugation (AUC). We have determined the solution structure of AqNusB using NMR. We have investigated NusB/ NusE binding using ITC and AUC. In addition, we present the binding surface of NusE on NusB determined using NMR chemical shift perturbation for the AqNusB/AqNusE complex and compare it to the NusE binding surface in the ternary EcNusB/ EcNusE/boxA RNA complex. Detailed investigation of these interactions also provides a viable structural interpretation of modified biological activity in a previously reported protein mutant. Though these interactions are discussed in terms of their role in prokaryotic genetics, the details of protein-protein and protein-RNA interactions may be applicable to eukaryotic genetic regulation as well.
Results

NusB from A. aeolicus
The AqNusB protein contains 148 amino acids (17.1 kDa) and is primarily α-helical, according to its CD spectrum, which shows a 75% α-helix, 9% β-turn, and 15% random coil secondary structure (Fig. 1a) . AqNusB eluted at 13.8 ml in a gel-filtration study, which corresponds to a monomeric NusB protein of 17(± 0.3) kDa (Fig. 1b) . This result was confirmed by AUC, which observed a molecular mass of 18(± 1) kDa (Fig. 1c) . AqNusB remains monomeric in solution at concentrations up to 0.7 mM. The 1 H, 15 N, and 13 C assignments have been made using standard triple-resonance NMR experiments on 13 C, 15 N-labeled AqNusB (see Materials and Methods) and are available at the BioMagResBank (accession number 15312). Assignments are shown on the 1 H-15 N heteronuclear single quantum coherence (HSQC) spectrum of AqNusB in Fig. 2a . The sequential assignments are 98% complete: 1 residue (R2) has no assignments and 7 residues (M1, R2, Y3, R4, K139, L145, and S147) have no observable NH resonance due to exchange broadening. The aromatic side chains are completely sequentially assigned. A second minor set of through-bond correlation peaks was noted for residues K134-S146. AqNusB is 10 residues longer at the C-terminus, as compared to the EcNusB protein sequence, and it is this extension that shows conformational variability.
The solution structure of AqNusB was determined to high resolution using calibrated 3D and 4D nuclear Overhauser enhancement spectroscopy (NOESY) spectra, automated NOESY assignment, and structure calculation using the PASD (probabilistic assignment algorithm for automated structure determination) program 13 and was subsequently refined using XPLOR-NIH with the addition of 1 D NH residual dipolar couplings (RDCs) (see Materials and Methods). A summary of restraints and structure quality data is provided in Table 1 . The average rmsd between the backbone atoms of 15 lowest energy structures (residues 3-135) is 0.45 Å (Fig. 2b ). Structural quality is demonstrated by a low rmsd of the covalent geometry to ideal values. Evaluation of the backbone torsion angles using PROCHECK 14 found that 99% of these fall within the allowed regions of the Ramachandran map. The 1% of residues in the disallowed region are found in loops between the helices. The solution structure of AqNusB reveals an all α-helical protein similar in overall fold to known NusB proteins (Fig. 3) . AqNusB contains seven helices: α 1 (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) , α 2 (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) , α 3 (41-55), α 4 (59-69), α 5 (79-94), α 6 (100-113), and α 7 (117-134). For convenience, the structure can be described as two subdomains consisting of α 1 -α 3 and α 4 -α 7 that are oriented at an angle of 127°with respect to each other (determined by the angle between the helical axes of α 1 and α 5 ). This description does not imply motion between helices for any portion of the structure. There are multiple NOE contacts between all helices, including α 1 and α 5 (see Fig. 2 in Ref. 10 ). In addition, the low backbone rmsd over all helices displayed in Fig. 2b supports the stability and lack of flexibility of the NusB structure.
NusE from A. aeolicus
AqNusE contains less ordered structure in solution than the AqNusB protein. The CD spectrum in Fig.  4a indicates that the secondary structure of NusE contains only 18% α-helix and 30% β-sheet, with the remainder showing 22% β-turn and 30% random coil. In addition, the 1 H-15 N HSQC spectrum of AqNusE exhibits an extremely overlapped, broadened spectral region with very few individually distinct peaks (data not shown). These results confirm the paucity of defined secondary structure or globular fold for the AqNusE protein free in solution. The calculated molecular mass of AqNusE from the amino acid sequence is 13.5 kDa. Sizeexclusion chromatography on a calibrated column shows the molecular mass of AqNusE to be 14(± 1) kDa (Fig. 4b) . Analysis of the sedimentation equilibrium data for AqNusE gives a molecular mass of 18.0(± 1.1) kDa from a fit to an ideal single species. However, the best fit to the data is obtained when a monomer ↔ dimer equilibrium model is used with a resulting K d = 180(± 25) μM (Fig. 4c) . Indeed, initial AUC data analysis was complicated by the tendency of AqNusE to form higher-order aggregates.
AqNusB/AqNusE interaction
The binding interaction between AqNusB and AqNusE was analyzed using ITC, AUC, and NMR. The optimal buffer conditions are different for the AqNusB and AqNusE proteins individually, but because the limiting factor in complex formation is the low solubility of AqNusE, the AqNusE buffer conditions were used for all experiments on the heterodimer complex (see Materials and Methods for details). The physical characteristics of AqNusB are not affected by the change in buffer conditions, since the CD spectrum is identical and the HSQC spectrum is very similar in either buffer. The interaction between AqNusB and AqNusE was measured using ITC (Fig. 5) , which shows that AqNusB and AqNusE bind to form a heterodimer. From the sign of the heat of the reaction (Fig. 5 , upper panel), it is apparent that formation of the AqNusB/AqNusE complex is an endothermic event. The titration curve was fit to a single binding e PROCHECK analysis of ϕ,ψ torsion angle distribution (% most favored/% additionally allowed/% generously allowed/% disallowed). AUC methods were used to analyze the AqNusB interaction with AqNusE in more detail. Initial AUC analysis gives a weight-averaged molecular mass of 50(± 0.6) kDa ( Supplementary Fig. 1 ). Analysis of the sedimentation equilibrium data versus concentration indicated an increase in molecular mass with concentration ( Supplementary Fig. 2 ). From these data, it is clear that the AqNusB:AqNusE heterodimer self-associates to form a 2:2 complex. The sedimentation equilibrium data were then fit to a self-association model, which yields a K d of 10 μM for (AqNusB:AqNusE) 2 ↔ 2(AqNusB:AqNusE) (Supplementary Fig. 3) . A sedimentation velocity experiment, conducted at 10 μM complex, was used to see if we could detect the presence of a 1:1 complex. This experiment determines the size of the complex from an estimate of the diffusion coefficient (Supplementary Fig. 4 ). From these data, a homogeneous system with a molecular mass of ∼35 kDa was observed.
Binding site of AqNusE on AqNusB
A chemical shift perturbation study was carried out by NMR to identify the binding site of AqNusE on AqNusB. At the concentration of the NMR sample (50 μM), the AqNusB:AqNusE complex exists in a 2:2 stoichiometry with a molecular mass of 62 kDa. Thus, perdeuteration of AqNusB was required along with the use of the 1 H-15 N transverse relaxation-optimized spectroscopy (TROSY)- Size-exclusion data of AqNusE at 5 μM. AqNusE elutes at 14.6 ml, corresponding to 14(±1) kDa, using a calibrated curve (see Materials and Methods). The expected molecular mass from the amino acid sequence is 13.5 kDa. A dilution factor of 1.5-2 was taken into consideration for the column. (c) Sedimentation equilibrium results for a 50-μM sample of AqNusE yields a molecular mass of 18(± 1.1) kDa. The data fit best to a monomer ↔ dimer model with a resulting K d = 180(± 25) μM. 15 in order to obtain a well-resolved spectrum of the NusE-bound AqNusB protein.
HSQC method
Chemical shift changes (Δδ) were observed in a subset of the TROSY-HSQC peaks when unlabeled AqNusE is bound, compared to the TROSY-HSQC peaks in the spectrum of free 2 H, 15 N AqNusB (Fig.  6a) . These Δδ are localized to several places on the surface of AqNusB and are depicted in Fig. 6b . Two localized regions of Δδ were found. Residues Y16-E23 comprise the C-terminal end of helix α 1 and the loop between helices α 1 and α2; residues S63-E81 include part of helix α 4 and the loop between helices α 4 and α 5 . Residues F122, G125, A129, E140, and E141 also show significant Δδ upon NusE binding and are located on helix α 7 (Fig. 6b) .
Binding in the ternary NusB/NusE/RNA E. coli complex All attempts to form an EcNusB/EcNusE complex in solution resulted in precipitation of the proteins, likely due to the limited solubility of EcNusE beyond ∼ 10 μM. Since the EcNusB/boxA RNA complex is soluble up to 300 μM, we attempted to bind EcNusE to this complex under the assumption that the binding event may keep more EcNusE in solution. A point mutant of EcNusB (C12A) was used in these studies to avoid protein-protein crosslinking by disulfide bond formation between the single, free Cys in EcNusB (see Materials and Methods). For simplicity, we will hereinafter refer to the C12A EcNusB protein as EcNusB. A sample of 2 H, 15 N-labeled EcNusB was combined with unlabeled boxA RNA at a 1:1.2 ratio, and an HSQC spectrum was collected. For the EcNusB/boxA RNA complex, many HSQC peaks had significant Δδ as compared to the free EcNusB protein, 7 indicating possible adjustments in EcNusB to accommodate RNA binding or perhaps a large binding surface. Hence, the peaks in the EcNusB/boxA RNA spectrum had to be reassigned to specific residues using standard backbone triple-resonance experiments on a complex of 13 C, 15 N EcNusB/unlabeled boxA RNA (A. S. Altieri and R. A. Byrd, personal communication). These data and analysis of the EcNusB/boxA RNA complex will be presented elsewhere. This EcNusB/boxA sample was diluted and co-concentrated with EcNusE to 20 μM. The 2 ) 1/2 versus residue number for E. coli (red) and Aquifex NusB (green).
HSQC spectrum of the ternary complex overlaid well with the assigned spectrum of the EcNusB/ RNA complex. Several residues exhibited chemical shift differences between EcNusB/RNA in the absence and presence of EcNusE (Fig. 7a) . The peaks were assigned by nearest peak inspection. The observed Δδ between the spectrum of EcNusB bound to RNA and the spectrum of EcNusB in the EcNusB/EcNusE/RNA ternary complex allow mapping of the binding interface of NusE onto NusB/RNA in this complex. The chemical shift perturbation data are mapped on the EcNusB solution structure in Fig. 7b . The ribbon diagram is given on the left while the surface representation is provided on the right. The residues with less or no chemical shift perturbations are colored blue. From the figure, it is seen that significantly perturbed residues include part of the loop between helices α 4 and α 5 (Y61-V80), part of the surface of helix α 7 (G125, V126), and six residues (S113-D118) forming the loop between α 6 and α 7 . Residue Y18 of helix α 1 and some nearby residues also show some perturbations when EcNusE binds. A comparison of the chemical shift perturbation data is plotted against the residues for EcNusB (i) and AqNusB (ii) in Fig.  7c . The residues along the x-axis are aligned as previously reported 10 . For ease of visual comparison, residues with Δδ beyond the orange line are colored orange in Figs. 6b and 7b for the AqNusB and EcNusB structures, respectively. Similarly, the residues with Δδ beyond the yellow line and below the orange line are colored yellow in Figs. 6b and 7b.
Discussion
Solution structure of AqNusB AqNusB was characterized above as a fully folded and monomeric protein in solution by NMR, ultracentrifugation, and gel-filtration studies. The highresolution solution structure of AqNusB (2JR0) shows an all α-helical fold that is very similar to the structures of NusB from E. coli, M. tuberculosis, and T. maritima. A superposition of the AqNusB structure to the family of solved NusB structures indicates that they are all highly similar (Fig. 3b-d) . The AqNusB and NusB protein from T. maritima (TmaNusB) (1TZT) structures (Fig. 3b ) match particularly well with a 1.8-Å backbone rmsd. The rmsd between the EcNusB (1EY1) and AqNusB solution structures is 2.2 Å. Helix α 3 is closer to the core of the protein in AqNusB than it is in EcNusB, giving AqNusB a more compact structure (Fig. 3c) . The rmsd between AqNusB and MtbNusB (1EYV) is 2.7 Å over helices α 1 and α 3 -α 7 (Fig. 3d) . Helix α 2 is further away from α 1 in MtbNusB, which is attributed to the dimer contacts between helix α 2 to α 2 ′ in the MtbNusB crystal structure. Comparison of the various NusB homologue structures indicates a consistently conserved structure, thus implying a consistent molecular interaction mechanism.
Characterization of AqNusE
The inherent insolubility and paucity of defined structural elements we observed for the free EcNusE protein have been noted by others 7, 8 and have been reported for NusE homologues as well. 9 Despite the increased solubility of the AqNusE homologue over EcNusE, we observe it to be only partly folded in solution based on CD and NMR spectra. As was pointed out in the study of MtbNusE, analysis of the NusE structure as it is found in the crystal of the 30S ribosomal complex from Thermus thermophilus 16, 17 provides an explanation of its solution behavior. The ribosome structure shows that NusE (identical with ribosomal protein S10 in the complex) consists of two α-helices from 13 to 30 and from 80 to 87 and two sections of β-sheet, which involve residues 5-9 and 95-99. In addition, the structure shows a large loop of extended structure from residues 43-69 that is deeply intertwined within the protein-RNA complex. The extended loop and α-helix (13-30) make extensive contacts to the rRNA, and the loop also makes hydrophobic contacts with the S3 and S14 proteins. 17 It is likely that these extensive interactions stabilize the NusE structure in the ribosomal complex. The amount of regular secondary structure present in NusE in this complex is consistent with our observed CD results on AqNusE free in solution and also as reported for NusE homologues. 9 Therefore, it appears that NusE retains its secondary structural elements in the absence of contacts with other proteins or RNA, 18 but the area of extended loop conformation in the ribosomal complex is likely disordered in free NusE.
The ultracentrifugation data for AqNusE indicate that it does not behave as a single monomeric species in solution but appreciably self-associates at concentrations above 180 μM. The presence of monomer-dimer equilibria was also reported for MtbNusE in solution. 9 Formation of the MtbNusE dimer in that study was attributed to a single, free cysteine (C50) in the MtbNusE sequence that would reduce to form an intermolecular disulfide bond. MtbNusE became monomeric in the presence of excess reducing agent or when C50 was mutated to Ser using site-directed mutagenesis. 9 The AqNusE sequence also contains this single cysteine; however, in our case, AqNusE dimerization is not likely due to cysteine cross-linking since our data were run in the presence of excess reducing agent [300 μM Tris(2-carboxyethyl)phosphine (TCEP)]. The C50 residue is not conserved across NusE homologues; therefore, dimerization through this residue is not generally considered important to protein function.
Interaction of NusE and NusB
ITC shows moderate affinity binding between AqNusB and AqNusE with a K d of ∼ 1 μM. The endothermic nature of the ITC curve corroborates thermodynamic results from the MtbNusB/NusE heterodimer complex 9 and signifies an entropically driven reaction. It is likely that when the complex forms, there is a loss in entropy from more restricted protein translation and rotation, but there is a larger gain in entropy due to the release of ordered water molecules from the interaction surfaces. [19] [20] [21] If binding to NusB also imparts an increase in structure for the disordered regions of NusE, there would be an additional release of water molecules in going from an extended protein chain to a more compact form, which would also contribute to the increase in entropy. These results indicate that AqNusB/AqNusE binding may be driven by hydrophobic interactions.
Association of the AqNusB:AqNusE heterodimer to form a 2:2 complex is evident from the ultracentrifugation data. This result impacts all biophysical data collected on the AqNusB:AqNusE complex that are above ∼ 10 μM concentration, for which ≥ 50% will be in the 2:2 form. For the ITC and AUC studies, we have noted the difficulties in obtaining a clear, single species in solution, which is caused by the presence of both heterodimer and "tetramer" in the samples of the complex. During the ITC titration, two binding processes are occurring: (i) AqNusB binding to AqNusE and (ii) selfassociation of the heterodimer. It is reasonable to assume that the primary binding event is the AqNusB:AqNusE heterodimer formation, since (i) the binding affinity for formation of the heterodimer is 10 times greater than that for the tetramer and (ii) the first event must proceed to a measurable extent before the second process can take place. The nonideal appearance of the baseline in the ITC data may very well represent the secondary, tetramerization process. In spite of this complication, our ITC results provide a comparable K d for the AqNusB/AqNusE interaction (1 μM) to that reported previously for EcNusB:EcNusE (0.2 μM) from fluorescence anisotropy. 8 Because a 1:1 AqNusB/AqNusE complex is observed in the sedimentation velocity experiments and since the individual proteins do not have a tendency to self-associate at cellular concentrations, we believe that the 1:1 heterodimer complex is the physiologically relevant form. The observed self-association at higher (than cellular) concentrations could be caused by a structural adjustment of AqNusB or AqNusE when they bind to each other, which then exposes a new binding interface conducive to self-association.
Binding site of AqNusE on AqNusB
NMR studies indicate the binding site of AqNusE on AqNusB. Residues showing significant chemical shift perturbation when AqNusE binds to AqNusB are depicted in Fig. 6b . There is a continuous stretch of perturbed residues between S63 and E81. These residues constitute part of helix α 4 and the loop between helices α 4 and α 5 . Several residues in this loop are conserved between NusB homologues: I64, I65, H68, L69, W72, I74, D75, L77, and V80. Also, several aliphatic residues on the protein surface formed by this loop create a hydrophobic patch: I64, I65, L69, I74, L77, and V80. Helix α 7 is also highly conserved, and some of the conserved surface residues such as F122, G125, and A129 show significant perturbation upon binding to AqNusE. These residues on α 7 are in structural proximity to the loop formed by residues S63-E81 in AqNusB and contribute to the hydrophobic patch formed by the loop. One other significant region of chemical shift perturbation is the loop between helix α 1 and α 2 comprising residues Y16-E23. The surface area formed by these residues is adjacent to the surface at S63-E81. A part of helix α 2 (residues 33-35) also shows chemical shift differences between the bound and free form of AqNusB. Since it is not near the regions described above, these may be secondary shifts due to slight structural adjustment of α 2 as AqNusE interacts with the loop between α 1 and α 2 . The chemical shift differences of E140 and E141 at the C-terminus could be accounted for in a similar fashion. The presence of highly conserved NusB residues Y16, L22, D64, L69, L74, L78, V80, F122, and V126 at the binding interface of NusB and NusE and the fact that the NusE sequence is 94% identical across its homologues 9 suggest that the binding interface would be very similar between the family of NusB and NusE proteins.
NusE binding to NusB/boxA RNA
The role of NusB and NusE in phage λ antitermination also involves their interaction with boxA RNA. The boxA RNA sites from different bacteriophages vary somewhat in sequence, as they do even for the leftward (nutL) and rightward (nutR) transcription directions in phage λ 1 . The antitermination function of NusB in bacterial cells also requires binding to boxA RNA sequences, which are present at the rRNA transcription sites. These boxA sequences may differ between each bacterium. To date, the boxA RNA sequence specific for AqNusB has not been found. Nevertheless, we tested whether consensus boxA RNA (3′-CGCU-CUUUAACA-5′) would bind to the AqNusB protein. Even at an excess of RNA, no shifts were observed in the HSQC spectrum of AqNusB in the presence of consensus boxA RNA. In a similar study, MtbNusB did not bind to consensus boxA RNA in vitro 9 and TmaNusB was found to exhibit weak binding to a variant of the boxA sequence. 12 The consensus boxA sequence does, however, bind specifically to EcNusB, 7 and the resulting 20 kDa complex is soluble to ∼ 300 μM. Therefore, we utilized the homologous E. coli NusB:NusE system (EcNusB:EcNusE) in complex with boxA RNA to analyze the binding site of NusE on NusB/RNA.
The binding of EcNusE in the ternary E. coli complex was studied by observing differences in the HSQC spectrum between 2 H, 15 N EcNusB/boxA RNA and 2 H, 15 N EcNusB/boxA/EcNusE (Fig. 7a) . The observed chemical shift perturbations are mapped onto the free EcNusB structure in Fig. 7b . These data show that the loop between residues Y61 and V80 and the intervening region between helices α 4 and α 5 are central to the binding interface. Some residues on the surface of helix α 7 are shifted and contiguous with the Y61-V80 loop: G125, V126, and possibly F122. A region at the C-terminal end of α 1 (Y18-Q21) is also perturbed. A comparison of the chemical shift perturbations (Δδ) observed for AqNusB (i) and EcNusB/RNA (ii) when the respective NusE binds is presented in Fig. 7c . The shift changes common to the NusE interface in both proteins are the loop between helices α 4 and α 5 (residues 60-81) and the surface residues (G125, K129, and probably F122) of helix α 7 . The loop between helices α 1 and α 2 is also perturbed in both complexes, although the region on AqNusB is a few residues longer here. On the other hand, residues S113-D118 are perturbed in EcNusB/RNA with EcNusE but are unperturbed when AqNusB binds AqNusE. Except for these two differences, the NusE binding interface is very similar between the AqNusB/AqNusE and EcNusB/boxA/EcNusE complexes. The similarity of the interaction surface of NusB with NusE proteins from two different bacteria emphasizes that the NusB/NusE interface, defined here for the first time, is likely to be similar across all NusB and NusE homologues.
As mentioned above, loop residues S113-D118 show large Δδ when EcNusB/RNA interacts with EcNusE ( Fig. 7a-c) . Though the surface of S113-D118 is not very far from the rest of the binding interface (∼10 Å), this region was not perturbed in the AqNusB/AqNusE interaction. It is possible that S113-D118 comes into proximity to the NusE binding interface by an adjustment of the EcNusB structure when RNA binds. This loop is important for complex formation and for antitermination activity. When EcNusB residue D118 is mutated to Asn in a genetics assay (nusB101), this D118N mutant rescues defective antitermination caused by a NusA mutation (nusA1) or a NusE mutation (nusE71). 22 This rescue activity requires the presence of boxA RNA. 22 Evidently, D118N EcNusB recognizes boxA RNA better than wild-type EcNusB, which suggests that D118 is part of the contact surface of boxA RNA on EcNusB. 22 In support of this hypothesis, D118 shows considerable Δδ between the boxA RNAbound and free EcNusB HSQC spectra (A. S. Altieri and R. A. Byrd, personal communication). As EcNusE is added to the EcNusB/boxA RNA complex, the EcNusB D118 HSQC peak shifts further, showing that it is additionally affected by binding to EcNusE. In order to affect this, the S113-D118 loop in EcNusB could adjust its position when it binds to RNA such that it is then near the interaction surface of EcNusE. Since the same residue, D118, is affected by interaction of NusB with both factors, NusE and boxA RNA are likely to be proximal in the ternary complex. Despite the localized differences in this loop between the binary and ternary complexes, the remaining data indicate that the overall binding surface of NusE on NusB is likely similar across all other NusB and NusE homologues. In addition, by comparing Figs. 6b and 7b (or Fig. 7c) , it is apparent that NusE binds to NusB similarly in the absence or presence of boxA RNA.
Biological implications
It is clear that one function of NusE is to increase the affinity of boxA RNA for NusB, and it does so by 10-fold. The dissociation constant of the NusB and boxA RNA interaction is ∼ 2 μM as detected by surface plasmon resonance, 7 fluorescence, 8 and ITC (A. S. Altieri and R. A. Byrd, personal communication) studies. However, the dissociation constant of boxA for the EcNusB/EcNusE to form NusB/NusE/ RNA complex is 200 nM. 7, 8 It is of considerable interest to look for features of the NusB/NusE binary complex that could contribute to the formation of the ternary assembly and, thus, could also be important to the function of antitermination.
The electrostatic charge surfaces of the two solution structures of AqNusB and EcNusB are presented in Fig. 8a and b, respectively. The surface charge distribution looks similar for the two proteins. In reference to Fig. 8a and b, the front surface has a few negatively charged regions, whereas the back surface (not displayed) contains some positively charged patches. Two conserved charged residues, D62 and D75 (or D63 and E75 in EcNusB), are at the NusE binding interface and impart a partial negative charge. These residues may be important contacts to NusE. A previous EcNusE mutant (nusE71) that aborts λN-mediated transcription antitermination 22, 24 is an alanine to aspartic acid point mutation at position 86 on EcNusE. It is possible that if the hydrophobic A86 of wild-type NusE is at the NusB binding surface, the acidic mutation may destabilize the NusB/NusE interaction and cause defective antitermination.
Aromatic residues have been shown to be important in protein-nucleic acid recognition, since aromatic side chains are able to make favorable stacking interactions with nucleic acid bases, 25 particularly in the case of non-base-paired nucleic acid strands. The NusB family has several conserved aromatic residues in their sequence. Some of these are at or near the surface of the EcNusB structure (Y18, Y69, F114, and F122), while Y16, H68, Y114, and F122 are at the surface of the AqNusB structure. In addition, these conserved aromatic surface residues are affected by NusE binding to NusB in either the binary A. aeolicus complex or the ternary E. coli complex. These combined observations suggest that these aromatic residues, and therefore possibly also NusE, may be close to RNA in the ternary complex. If the boxA segment is deleted from the nut region (boxAΔ37), genetic assays report that antitermination has reduced dependence on NusE. 5 It is also known that free NusE binds RNA nonspecifically 8 in vitro and that NusE also has contacts to rRNA in the 30S ribosomal subunit structure. 17 Therefore, NusE may have direct contacts to boxA RNA in the ternary complex. As an indication of where RNA may interact with NusE, we notice two positively charged regions composed of residues R43, R45, R46, R66, K55, H56, and K57 that make rRNA contacts with rRNA helices H31, H39, and H41 in the 30S subunit crystal structure. These residues may also have direct contacts with boxA RNA in the ternary NusB/NusE/boxA RNA complex, and such interactions could significantly increase the stability of the ternary complex.
In Fig. 8c and d, the surface representations of AqNusB and EcNusB are drawn, with exposed or partially exposed hydrophobic residues colored green. The C-terminus of helix α 4 (S63-L69) and the loop between α 4 and α 5 (L70-E81) are central to the binding interface. AqNusB shows several hydrophobic residues in this region: I64, I65, L69, W72, I74, L77, and V80. For this region of EcNusB, residues L62, M66, Y69, L70, L73, L74, L77, and V80 create a hydrophobic surface patch. The presence of a significant number of hydrophobic residues at the NusE interface indicates that hydrophobic interactions could drive the formation of the NusB/NusE complex. In a comparison of NusB homologue sequences, a region of highly conserved residues along helix α 7 has been pointed out as a possible RNA binding site. As evident in Figs. 6b and 7b , the 63-80 loop sits on top of α 7 . Due to the loop, some of the conserved hydrophobic residues of α 7 , which could be crucial for NusB-RNA interaction, are buried. As indicated by NMR studies, the 63-80 loop undergoes significant chemical shift changes and possible structural adjustment when NusE binds. This structural modification could be enough to expose additional hydrophobic surface area around α 7 and tighten the intermolecular contacts between NusB and RNA.
In conclusion, we have determined the solution structure of AqNusB and studied the AqNusB/ AqNusE interaction. Various biophysical methods show that AqNusB is a monomer over a wide range of concentrations but that AqNusE exists in a monomer-dimer equilibrium with a dissociation constant of ∼180 μM. NMR chemical shift mapping provides details of the binding interface on AqNusB when AqNusE is bound. A similar binding region was identified in the E. coli system when the EcNusB/RNA complex binds to EcNusE to form the ternary NusB/NusE/RNA complex. Analysis of residues at the interface suggests that NusE binds to NusB largely through hydrophobic interactions. It is also noted that conserved aromatic residues that could be crucial for NusB/RNA interaction are also perturbed by the NusB/NusE interaction. The present study also shows that D118, which is the site of an important genetic mutation, is also perturbed by the NusB/NusE interaction in the presence of RNA. Previous genetic assays 5 and ultracentrifugation studies 8 have shown additional but nonspecific binding between NusE and RNA as well. Hence, NusB, NusE, and boxA RNA all interact with each other, and the sum of the interactions between the three factors is at a higher affinity than for any of the two factors alone. One possible explanation from evidence gained here is that NusE binding to NusB may induce a modification of the 63-81 loop, which optimizes contacts between NusB and boxA RNA. With NusB providing the desired specificity to the complex, there is likely a triangular network of interactions between the three factors to enhance the stability of the ternary complex.
Materials and Methods
Cloning, expression, and purification of AqNusB
The open reading frame (ORF) encoding NusB (AAC06491) was amplified from genomic DNA by the polymerase chain reaction (PCR) using the following oligodeoxyribonucleotide primers: (i) 5′-CCT CCG CAT ATG AGG TAT CGG AAA GGT GCA AG-3′ and (ii) 5′-TCC CGC GGA TCC ATT ACT CTG ATT TTA AAC TTG GTT TTT CTT C-3′. The resulting PCR amplicon was cleaved with NdeI and BamHI and then ligated with the NdeI/BamHI vector backbone of pET11c (Novagen, Madison, WI) to create the A. aeolicus NusB expression vector pKM772. The nucleotide sequence of the insert was confirmed experimentally. Frozen cells were grown in 1 ml LBC at 37°C for 6 h. They were then centrifuged and resuspended in 50 ml M9 minimal media (1 l of M9 media contained 1 g 15 NH 4 Cl and 2 g D-13 C 6 -glucose). The cells were incubated overnight in M9 at 37°C. The overnight culture was added to 1 l M9 medium and allowed to grow at 37°C. The protein was induced at an A 600 = 0.8-1.0, using 1 mM IPTG, and grown at 37°C overnight. After centrifugation, the pellet was resuspended in 30 mM KPO 4 . The cells were cracked by sonication and heated to 90°C for 30 min. They were then centrifuged, and the supernatant was applied to an SP Sepharose ion-exchange column and eluted with 1 M NaCl in 30 mM KPO 4 phosphate buffer. The purity of the protein was assessed by SDS-PAGE, and the relative isotope enrichment was characterized by mass spectroscopy. The isotope enrichment was assessed to be 98% 15 N and 98% 13 C. The cells were consecutively incubated in 50 ml M9 minimal media in three stages to prepare (perdeuterated) 2 2 H-12 C 6 -glucose). The rest of the procedure was as described above. The isotope enrichment was assessed to be 98% 15 N and 95% 2 H (nonexchangeable).
Cloning, expression, and purification of AqNusE
The ORF encoding A. aeolicus NusE (ACC06399) was amplified by PCR using the following oligodeoxyribonucleotide primers: (i) 5′-GGG GAC AAG TTT GTA CAA AAA AGC AGG CTC GGA GAA CCT GTA CTT CCA GGG CAT GGA ACA GGA AAA AAT AAG C-3′ and (ii) 5′-GGG GAC CAC TTT GTA CAA GAA AGC TGG GTT ATT AAC CTC TCA TCT TCA CTT CTA CGT C-3′. The resulting PCR amplicon was inserted into pDONR201 (Invitrogen, Carlsbad, CA) by Gateway recombinational cloning to create pKM620, and the nucleotide sequence of the insert was confirmed experimentally. Next, the NusE ORF, now with a tobacco etch virus protease cleavage site joined in-frame to its N-terminus, was recombined into the maltose-binding protein fusion vector pKM596 26 to generate the plasmid expression vector pKM591. The maltosebinding protein-NusE fusion protein was expressed in E. coli BL21(DE3)-RIL CodonPlus cells (Stratagene, Valencia, CA). AqNusE was amplified by PCR based on plasmid pKM620. The PCR 5′ primer has an NdeI restriction site at the 5′ end, while the 3′ primer carries a His 6 sequence followed by a stop codon and a BamHI site. The PCR product was digested by these two enzymes and inserted into pET3a (Novagen) vector. Frozen cells were grown in 1 ml LBC at 37°C for 6 h. They were then centrifuged and resuspended in 100 ml M9 minimal media containing the same amount of 14 NH 4 Cl and D-12 C 6 -glucose as described above. A 1-l culture was grown in M9 overnight. The cells were induced when the A 600 reached 0.8-1.0, with 0.2 mM IPTG at room temperature. These cells were then harvested and resuspended in 25 ml lysis buffer (50 mM NaPO 4 and 100 mM NaCl at pH 7.0). A microfluidizer (Microfluidics Corp.) was used to crack the cells. After centrifugation, the cell pellet was washed with 50 ml lysis buffer and centrifuged again. The pellet was resuspended in 6 M Gn·HCl, 300 mM NaCl, 50 mM NaPO 4 , and 4 mM DTT buffer at pH 7.0 and 4°C. The resulting combined supernatant was applied to a Ni 2+ affinity column and eluted with 6 M Gn·HCl, 150 mM imidazole, 300 mM NaCl, 50 mM NaPO 4 , and 4 mM DTT at pH 7.0. The eluted fractions were pooled together dialyzed into 4 M urea, 25 mM KPO 4 , and 2 mM DTT at pH 5.5. The protein was refolded by slowly dialyzing away the urea from 4 to 0 M in the following buffer: 25 mM KPO 4 and 2 mM DTT at pH 5.5. Protein purity was verified by SDS-PAGE and mass spectrometry. For all biophysical experiments, the AqNusE protein was dialyzed into 25 mM KPO 4 , 100 mM KCl, and 300 μM TCEP at pH 5.5.
Expression and purification of EcNusB and EcNusE
Subcloning of the nusB gene into the pET3a vector was achieved by PCR using a pair of oligomers bearing NdeI for the forward oligo and BamHI for the reverse oligo and using the pNC139 nusB clone (gift from D.L. Court, NCI) as template. The PCR product was digested with NdeI and BamHI enzymes and ligated into a pET3a vector. A C12A mutation was introduced into wild-type NusB using a pair of complementary oligomers bearing the mismatch at Cys12 for Ala. Mutagenesis was performed using QuikChange Mutagenesis Kit (Stratagene) using the nusB/ pET3a clone.
The pET3a plasmid containing the nusB mutant sequence (C12A) was used to transform E. coli BL21 DE3 (pLysS) cells.
15 N-labeled samples were expressed in cells grown on M9 minimal media containing 1 g/l 15 NH 4 Cl and 2 g/l glucose. 13 C, 15 N-labeled samples were expressed in M9 minimal media containing 1 g/l 15 NH 4 Cl and 2 g/l 13 C glucose, and in both cases, media were supplemented with biotin, thiamin, and 100 μg/ml carbenicillin. Cells were grown at 37°C, induced with 0.5 mM IPTG at A 600 ∼ 0.8, harvested 4 h later, and frozen at −80°C. The cells were then defrosted and suspended in 20 ml of buffer containing 300 mM NaCl and 50 mM sodium phosphate (Buffer A). To this cell suspension, 20 μl of RNase at 10 mg/ml concentration, 20 μl of DNase at 10 U/μl concentration, and 5 mM MgSO 4 were added. The cells were allowed to sit at room temperature for 30 min and then centrifuged. The resultant pellet was then washed in Buffer A and centrifuged twice and was finally dissolved in buffer containing 8 M urea and 50 mM sodium phosphate at pH 6.8. The sample was then centrifuged to clarity, and the supernatant was loaded onto a HiLoad 26/10 SP Sepharose high-performance cationexchange column (Pharmacia) and purified using a 0-1 M NaCl gradient (in 8 M urea and 50 mM sodium phosphate at pH 6.8). Fractions containing NusB were pooled for refolding by dialysis against decreasing amounts of urea in phosphate buffer at pH 6.8. The refolded protein was run on an SP Sepharose column a second time in the same buffer system as described above for the first SP column, except without urea. The purified, refolded protein was then concentrated for NMR to 0.3 mM in 100 mM NaCl and 50 mM NaPO 4 at pH 6.8. The C12A point mutant of EcNusB was used to avoid protein-protein cross-linking. The C12 residue is not conserved across the family of NusB homologues; hence, it is not critical to NusB function. Additionally, the HSQC spectrum of C12A EcNusB is nearly superimposable with the wild-type EcNusB spectrum, and C12A EcNusB maintains wild-type RNA binding.
As a buffer control for the ternary binding data, an identical EcNusB sample was prepared with 10 mM urea in the buffer. The HSQC spectra of EcNusB with and without the urea were identical. The EcNusB/boxA RNA sample was then prepared by adding boxA RNA (3′-UGCUCUUUAACA-5′; Oligos Etc., Wilsonville, OR) to 2 H, 15 N EcNusB and co-concentrating to ∼260 μM with an Amicon stirred cell using a membrane with a molecular weight cutoff of 1000 Da.
Plasmids of EcNusE were constructed as described earlier. 27 Frozen cells were grown in 1 ml LBC at 37°C for 6-8 h until the solution is visibly clouded. The cells were centrifuged and resuspended in 100 ml M9 minimal media containing 14 NH 4 Cl and D-12 C 6 -glucose. A 1 L culture in M9 was grown at 32°C overnight. Cells were induced when the A 600 reached 0.8-1.0, with 0.2 mM IPTG, and grown for 4 h at 42°C. These cells were then harvested and resuspended in 20 ml lysis buffer (50 mM NaPO 4 and 100 mM NaCl at pH 6.8). A microfluidizer (Microfluidics Corp.) was used to crack the cells, and the cells were centrifuged. The cell pellet was washed with 50 ml lysis buffer and centrifuged again. The pellet was resuspended in 8 M urea and 50 mM NaPO 4 buffer at pH 6.8 and swirled overnight at 4°C. The urea lysate was centrifuged to remove insolubles, and the supernatant was applied to an SP column and eluted with 8 M urea, 50 mM NaPO 4 , and 1 M NaCl at pH 6.8. The eluted fractions were pooled together and diluted with 8 M urea, 50 mM NaPO 4 , and 1 M NaCl at pH 6.8. The dilute protein was refolded by a three-step dialysis in these buffers: (i) 4 M urea, 50 mM NaPO 4 , and 500 mM NaCl at pH 6.8; (ii) 2 M urea, 50 mM NaPO 4 , and 250 mM NaCl at pH 6.8; and (iii) 0 M urea, 50 mM NaPO 4 , and 25 mM NaCl at pH 6.8. Protein purity was verified by SDS-PAGE and mass spectrometry. The ternary EcNusB/boxA/EcNusB sample for NMR was prepared by diluting the 2 H, 15 N EcNusB/RNA complex and then co-concentrating with EcNusE to 20 μM in the presence of 10 mM urea.
Sample preparation of AqNusB
NMR samples of AqNusB were ∼ 0.7 mM prepared in 50 mM phosphate and 200 mM KCl at pH 6.8. All NMR spectra were measured at 35°C. A 5%, 5.4-mm-diameter polyacrylamide gel was dried and then soaked in a 0.5-mM AqNusB protein solution overnight and finally stretched to 16 mm in length to measure NH RDCs. 28 An NMR sample of 2 H, 15 N AqNusB complexed with unlabeled AqNusE was prepared by dialyzing the two proteins in 25 mM phosphate, 100 mM KCl, and 200 μM TCEP buffer at pH 5.5 and then concentrating to 50 μM. Concentration of the AqNusB/AqNusE complex beyond 100 μM caused aggregation of the sample. All NMR spectra of the heterodimer complex were run at 25°C.
NMR spectroscopy and resonance assignments
All NMR spectra were collected on 600-and 800-MHz Varian INOVA spectrometers equipped with Nalorac triple-resonance gradient probes or Varian cryoprobes. 1 H, 15 N, and 13 C backbone resonances were assigned using standard 3D triple-resonance NMR experiments: HNCO, 29 HNCACB, 30 and CBCA(CO)NH. 29, 31, 32 The aliphatic side-chain resonances were assigned from C(CO)NH, 33 H(CCO)NH, 34 and HCCH-total correlated spectroscopy 35 spectra. Aromatic side chains were assigned from 3D CβHδ and CβHε spectra 36 and a 3D HCCH-aromatic TROSY. 15, 37 All NMR data were processed using NMRPipe. 38 The assignments were derived using ANSIG 39 software. Backbone ϕ/ψ torsion angle restraints were derived from a database correlating protein secondary structure and 13 44 and 4D 13 C/ 13 C HSQC-NOESY-HSQC, 100 ms. 45 The NOESY experiments were peak picked using ANSIG or SPARKY. Possible assignments for each NOE cross peak were then generated within PASD by comparing its chemical shift coordinates to the table of 1 H, 13 44 The resonances whose chemical shift matched with the coordinates of an NOE cross peak (within tolerance) were assigned to that cross peak. The 4939 NOESY cross peaks resulted in 112,629 assignments from the chemical shift matching protocol alone, and 438 of these had a single assignment. The intensities of these cross peaks were classified into distance bounds of 1.8-2.7 Å for highestintensity peaks (20%), 1.8-3.3 Å for medium-intensity peaks (30%), 1.8-5.0 Å for weak-intensity peaks (30%), and 1.8-6.0 Å for the very weak intensity peaks (the remaining 20%) and were subsequently used in structure determination.
Structure calculation and refinement PASD 13 consists of three successive passes of simulated annealing, employing a probabilistic method for the inactivation and reactivation of all NOE assignments on the fly during each pass. The algorithm relies on the observation that a correct set of restraints is correlated and generates forces to determine the same structure, whereas incorrect restraints are generally uncorrelated and their forces average out. The simulated annealing passes were set up as detailed in the original paper, at the end of which, 3174 restraints had probability N 0.9 and were included in the final NOE table. At the end of simulated annealing, PASD also provided a high-resolution fold (rmsd = 1.1 between the backbone atoms of the helices over 20 structures) for AqNusB. This initial fold was further refined in XPLOR by 2400 steps of simulated annealing at 400 K followed by 15,000 cooling steps of 0.005 ps to 100 K. In this refinement, PASD-derived NOEs, observed hydrogen bonds, and N-H RDCs (Da = − 13.2 and Rh = 0.67) were used in the list of restraints. The force constants used in the refinement stage of structure calculation were 50 kcal mol −1 Å −2 , 200 kcal mol −1 deg −2 , and 0.1 kcal mol −1 Hz −2 for NOEs, dihedral angles, and RDCs, respectively.
Size-exclusion chromatography
Gel-filtration experiments were performed at room temperature using a Tricon 30/100 Superdex75 column with a separation range of 3-70 kDa connected to an FPLC system (AKTA). Absorbance was monitored at 280 nm, and 500-μl aliquot samples were analyzed using a flow rate of 0.5 ml/min. The column was calibrated using a standard curve of elution volume versus log of molecular mass made with the following molecular mass standards: ribonuclease, 13.7 kDa; chymotrypsinogen A, 26 kDa; ovalbumin, 43 kDa; and bovine serum albumin, 67 kDa. The AqNusB sample was in 25 mM potassium phosphate and 100 mM KCl buffer at pH 5.5. The AqNusE sample was in an identical buffer with 200 μM TCEP to prevent dimerization through the single, free Cys of NusE.
CD spectroscopy
The CD spectra of AqNusB and AqNusE were measured with an Aviv 202 polarimeter. The sample temperature was controlled at 25°C with a Peltier thermostat. The AqNusB sample was in 50 mM potassium phosphate and 200 mM KCl buffer at pH 6.5. The AqNusE sample was in 25 mM potassium phosphate, 100 mM KCl, and 200 μM TCEP buffer at pH 5.5. CD spectra were obtained at a protein concentration of about 70 μM using a 1-mm-pathlength quartz cell at 25°C. The CD spectra shown are single-scan measurements.
ITC
Prior to the ITC titration, both proteins were dialyzed separately into a buffer of 25 mM KPO 4 , 100 mM KCl, and 200 μM TCEP at pH 5.5. The protein binding interactions were measured using a VP-ITC Microcalorimeter (MicroCal LLC, Northampton, MA) at 25°C. For the titration, 25-27 aliquots (10 μl each) of 100-200 μM AqNusB were injected into the ITC cell containing ∼ 1.4 ml of AqNusE at a concentration of 10 μM. The titration was preceded by a single 2-to 3-μl injection to eliminate the effect of diffusion at the protein/protein interface at the titration syringe tip during the thermal equilibration of the calorimeter prior to injections. The experiments were run at "Low feedback mode/gain" or at "No feedback" setting. The stirring speed was 300 rpm. The duration of injection in seconds was usually twice the value of the injection volume. An additional set of injections was run, with only buffer in the cell instead of AqNusE, to offset any thermodynamic effects from dilution of concentrated AqNusB in the syringe. The data from this "blank" experiment were subtracted from the main "protein-into-protein" data. Any dilution effects of AqNusE will be negligible since very small aliquots of AqNusB are used relative to the bulk volume of the ITC cell. The integrated heat of interaction values were fit using the "Origin 7.0"-based ITC data analysis software provided by MicroCal. There was a small amount of nonideal behavior noted for each titration point near the baseline, which may be indicative of a secondary thermodynamic process. These were excluded from the fit to the primary binding event by manual adjustment of the integration procedures, as necessary. The initial 2-to 3-μl titration point was always discarded. The data were fit to the "One set of sites" model, which yielded the binding affinity, the molar ratio, and the other thermodynamic parameters.
AUC AUC was carried out using a Beckman Optima XL-I analytical ultracentrifuge. Absorption optics, an An-60 Ti rotor, and standard double-sector centerpiece cells were used. Equilibrium measurements were made at 20°C, and concentration profiles were recorded after 16-20 h at either 18,000 rpm (AqNusB and AqNusE) or 16,550 rpm (AqNusB/AqNusE complex). Baselines were established by overspeeding at 45,000 rpm for 4 h. Data (the average of five scans collected using a radial step size of 0.001 cm) were analyzed using the standard Optima XL-I data analysis software. Protein partial specific volumes were calculated from amino acid compositions, 46, 47 and solvent density was estimated as previously described. 47 Sedimentation velocity measurements at 20°C were at 45,000 rpm for 3 h with data collection at 5-to 10-min intervals. Data (radial step size = 0.003 cm) were analyzed using the program DCDT+ version 2. 48 All of the protein samples were in 25 mM potassium phosphate and 100 mM KCl at pH 5.5. The AqNusE and AqNusB/ AqNusE samples also contained 200 μM TCEP.
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